seed
Stage
2019
Founded
2
Investors
About
Captain T Cell GmbH is a biotechnology company developing novel T-cell receptor (TCR) based immunotherapies. Their focus is on creating highly effective and safe TCR-T cell therapies for the treatment of solid tumors.
Explore Captain T Cell GmbH's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.